Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chadi Nabhan

Showing results (51-60 of 199) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|February 24, 2016
The evolving role of lenalidomide in non-Hodgkin lymphomaNatalie Galanina, Adam Petrich, Chadi Nabhan
Leukemia & Lymphoma|November 9, 2018
Acute myeloid leukemia in the elderly: what constitutes treatment value?Chadi Nabhan, Siddhesh Kamat, Jonathan Karl Kish
Journal of Oncology Practice|November 18, 2017
MACRA in Oncology Care: Are We Ready?Chadi Nabhan, Alima Tchafa, Bruce A Feinberg
Future Oncology (London, England)|June 30, 2020
Rituximab biosimilars in hematologic malignancies: the need for a real-world approachPilar Nava-Parada, Ahmed Shelbaya, Chadi Nabhan
The Oncologist|July 28, 2018
Barriers to Oncology Biosimilars Uptake in the United StatesChadi Nabhan, Amy Valley, Bruce A Feinberg
JAMA Oncology|July 17, 2015
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary EraChadi Nabhan, Gordana Raca, Y Lynn Wang
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2017
Lean: Targeted Therapy for Care DeliveryChadi Nabhan, Gregory Horner, Michael D Howell
Case Reports in Medicine|August 28, 2012
Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinomaAndrew Meyer, Rachel Angelica Mariani, Chadi Nabhan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Disclosing the cancer diagnosis:the myth and the truthChadi Nabhan, Jacob D Bitran, Clint Moore
JAMA Oncology|October 9, 2015
Prognosis in Chronic Lymphocytic Leukemia-ReplyChadi Nabhan, Gordana Raca, Y Lynn Wang
Pageof 20

Showing results (51-60 of 199) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|February 24, 2016
The evolving role of lenalidomide in non-Hodgkin lymphomaNatalie Galanina, Adam Petrich, Chadi Nabhan
Leukemia & Lymphoma|November 9, 2018
Acute myeloid leukemia in the elderly: what constitutes treatment value?Chadi Nabhan, Siddhesh Kamat, Jonathan Karl Kish
Journal of Oncology Practice|November 18, 2017
MACRA in Oncology Care: Are We Ready?Chadi Nabhan, Alima Tchafa, Bruce A Feinberg
Future Oncology (London, England)|June 30, 2020
Rituximab biosimilars in hematologic malignancies: the need for a real-world approachPilar Nava-Parada, Ahmed Shelbaya, Chadi Nabhan
The Oncologist|July 28, 2018
Barriers to Oncology Biosimilars Uptake in the United StatesChadi Nabhan, Amy Valley, Bruce A Feinberg
JAMA Oncology|July 17, 2015
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary EraChadi Nabhan, Gordana Raca, Y Lynn Wang
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2017
Lean: Targeted Therapy for Care DeliveryChadi Nabhan, Gregory Horner, Michael D Howell
Case Reports in Medicine|August 28, 2012
Lymphangitic pulmonary metastases in castrate-resistant prostate adenocarcinomaAndrew Meyer, Rachel Angelica Mariani, Chadi Nabhan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Disclosing the cancer diagnosis:the myth and the truthChadi Nabhan, Jacob D Bitran, Clint Moore
JAMA Oncology|October 9, 2015
Prognosis in Chronic Lymphocytic Leukemia-ReplyChadi Nabhan, Gordana Raca, Y Lynn Wang
Pageof 20